Health Care & Life Sciences » Pharmaceuticals | Taiko Pharmaceutical Co. Ltd.

Taiko Pharmaceutical Co. Ltd.

Taiko Pharmaceutical Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY98.77
Market Cap
JPY31.86 B
Shares Outstanding
14.34 M
Public Float
8.46 M

Profile

Address
ORIX Honmachi Building, 16F
Osaka Osaka 550
Japan
Employees -
Website http://www.seirogan.co.jp
Updated 07/08/2019
Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs, and sanitation control products. It operates through the following segments: Pharmaceuticals, Infection Control, and Others. The Pharmaceuticals segment handles the manufacture, procurement and sale of non-prescription (OTC) drugs in Japan and overseas.

Financials

View All

Hitoshi Shibata
Chairman
Takashi Shibata
President & Representative Director